American Century Companies Inc Neogenomics Inc Transaction History

American Century Companies Inc

$176 Billion
Q2 2025

A detailed history of American Century Companies Inc transactions in Neogenomics Inc stock. As of the latest transaction made, American Century Companies Inc holds 3,517,478 shares of NEO stock, worth $21.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,517,478

Previous 3,319,602 5.96%

Holding current value

$21.4 Million

Previous $31.5 Million 18.38%

% of portfolio

0.01%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$6.4 - $10.27 $1.27 Million - $2.03 Million	197,876 Added 5.96%	3,517,478 $25.7 Million
Q1 2025 May 13, 2025	BUY	$9.09 - $18.61 $3.88 Million - $7.93 Million	426,341 Added 14.74%	3,319,602 $31.5 Million
Q4 2024 Feb 11, 2025	SELL	$13.0 - $18.43 $1.72 Million - $2.45 Million	-132,683 Reduced 4.38%	2,893,261 $47.7 Million
Q3 2024 Nov 12, 2024	SELL	$13.4 - $17.73 $3.16 Million - $4.18 Million	-235,812 Reduced 7.23%	3,025,944 $44.6 Million
Q2 2024 Aug 07, 2024	BUY	$13.01 - $15.77 $2.17 Million - $2.64 Million	167,145 Added 5.4%	3,261,756 $45.2 Million
Q1 2024 May 14, 2024	BUY	$14.06 - $16.79 $15.5 Million - $18.5 Million	1,103,919 Added 55.45%	3,094,611 $48.6 Million
Q4 2023 Feb 13, 2024	BUY	$11.67 - $20.73 $23.2 Million - $41.3 Million	1,990,692 New	1,990,692 $32.2 Million
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $488,563 - $717,766	-40,211 Reduced 59.93%	26,882 $330,000
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $287,752 - $404,690	20,408 Added 43.71%	67,093 $1.08 Million
Q1 2023 May 11, 2023	BUY	$9.09 - $19.45 $137,068 - $293,286	15,079 Added 47.71%	46,685 $812,000
Q4 2022 Feb 13, 2023	BUY	$6.45 - $12.07 $203,858 - $381,484	31,606 New	31,606 $292,000
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $2.62 Million - $5.18 Million	-370,783 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$12.15 - $35.28 $2.49 Million - $7.22 Million	-204,557 Reduced 35.55%	370,783 $4.51 Million
Q4 2021 Feb 07, 2022	SELL	$30.49 - $48.49 $1.26 Million - $2 Million	-41,313 Reduced 6.7%	575,340 $19.6 Million
Q3 2021 Nov 10, 2021	BUY	$41.66 - $52.52 $2.7 Million - $3.41 Million	64,886 Added 11.76%	616,653 $29.7 Million
Q2 2021 Aug 05, 2021	SELL	$36.62 - $51.69 $82,504 - $116,457	-2,253 Reduced 0.41%	551,767 $24.9 Million
Q1 2021 May 14, 2021	SELL	$41.56 - $59.88 $5.61 Million - $8.08 Million	-134,906 Reduced 19.58%	554,020 $26.7 Million
Q4 2020 Feb 12, 2021	BUY	$36.08 - $56.47 $2.9 Million - $4.55 Million	80,487 Added 13.23%	688,926 $37.1 Million
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $2.2 Million - $2.67 Million	-66,080 Reduced 9.8%	608,439 $22.4 Million
Q2 2020 Aug 13, 2020	BUY	$24.21 - $31.02 $4.02 Million - $5.15 Million	165,912 Added 32.62%	674,519 $20.9 Million
Q1 2020 May 14, 2020	BUY	$20.5 - $34.53 $527,178 - $887,973	25,716 Added 5.33%	508,607 $14 Million
Q4 2019 Feb 12, 2020	BUY	$18.96 - $29.84 $1.23 Million - $1.94 Million	65,059 Added 15.57%	482,891 $14.1 Million
Q3 2019 Nov 13, 2019	SELL	$19.12 - $26.24 $5.18 Million - $7.11 Million	-270,791 Reduced 39.32%	417,832 $7.99 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $978,049 - $1.2 Million	49,977 Added 7.83%	688,623 $15.1 Million
Q1 2019 May 14, 2019	SELL	$12.14 - $20.46 $596,426 - $1.01 Million	-49,129 Reduced 7.14%	638,646 $0
Q4 2018 Feb 13, 2019	BUY	$11.24 - $18.5 $4.27 Million - $7.03 Million	380,041 Added 123.5%	687,775 $8.67 Million
Q3 2018 Nov 02, 2018	BUY	$12.5 - $15.38 $3.85 Million - $4.73 Million	307,734 New	307,734 $4.72 Million

Others Institutions Holding NEO

# of Institutions

307

Shares Held

129M

Call Options Held

1.1M

Put Options Held

296K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $765M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Neogenomics Inc Transaction History